Investing.com -- Coty Inc. has been downgraded by analysts at Deutsche Bank and Canaccord Genuity this week, with the firm’s flagging weakening fundamentals and mounting uncertainties for the beauty company. Deutsche Bank lowered its rating on Coty (NYSE:COTY) from Buy to Hold and cut its price target to $6 from $8, citing “slower category growth trends, particularly in the U.S.; new headwinds to navigate stemming from tariffs; and lingering questions pressuring execution against multiple growth drivers.” Advertisement: High Yield Savings Offers Earn up to 4.35% APY** with $5k balance View Offer Earn up to 4.00% APY with Savings Pods View Offer Earn up to 3.80% APY¹ & up to $300 Cash Bonus with Direct Deposit View Offer Powered by Money.com - Yahoo may earn commission from the links above. The firm warned that despite Coty’s initiatives, it now sees “an increasingly untenable path to long-term targets,” including the company’s 2028 EBITDA goal of $1.3–$1.4 billion. Canaccord also downgraded Coty to Hold, cutting its price target to $5 from $8 following what it described as “worsening trends for the business despite other beauty brands generally seeing resilient results.” The firm noted Coty’s prestige beauty segment, once seen as a bright spot, is now also showing signs of strain. “This is the third quarter in a row that management has had to lower expectations,” Canaccord said, highlighting ongoing global consumer uncertainty and normalizing beauty demand. Both firms also pointed to the uncertainty surrounding the potential sale of Coty’s Wella stake, which was once expected to help deleverage the company. While both Deutsche Bank and Canaccord acknowledged Coty’s strong brand assets, they emphasized near-term execution challenges and rising volatility. Related articles Analysts turn more cautious on Coty Inc. Coinbase to expand its derivatives offering with $2.9B acquisition of Deribit Root shares surge as Q1 earnings and revenue top estimates View Comments
Analysts turn more cautious on Coty Inc.
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...